Evaluation of Rheumatology Practice in Algeria During the Different Waves of the Covid19 Pandemic

Basic and Translational Research

1Bengana Bilal, 1Aridj Tarek, 1Abdellaoui Selma, 1Boukabous Abdenour, 1Lefkir Taffiani Salima 1University Hospital Center Of Beni Messous Background: The occurrence of the COVID-19 pandemic has disrupted the daily activity of rheumatologists especially during epidemic peaks, resulting in an upheaval in the management of chronic pathologies such as chronic inflammatory rheumatism (CIR). This has led to…

Behavioral Assessment of Algerian Patients with a Chronic Rheumatism Disease During Covid19 Pandemic

Clinical Research

1Bengana Bilal, 1Aridj Tarek, 1Abdellaoui Selma, 1Boukabous Abdenour, 1Lefkir Taffiani Salima 1University Hospital Center Of Beni Messous Background: The COVID19 pandemic has completely changed patient care with chronic pathologies following the incessant reorganization of care which each time adapted to the epidemic context. This prompted patients with chronic inflammatory rheumatism (CIR) to self-manage and take…

Antiphospholipid Syndrome with Diffuse Alveolar Hemorrhage: Case Report

Clinical Cases

1Amna Ahmed Almuhairi,1Aneja Ritu, 1Diab, Sehriban 1Sheikh Shakhbout Medical City Introduction: Diffuse alveolar hemorrhage (DAH) is a rare, potentially fatal presentation of antiphospholipid syndrome (APS) that can be triggered by infections, toxins or other factors. Due to rarity of DAH in APS, no randomized trials exist, and treatment is guided by case reports, case series,…

Biosimilar in Juvenile Idiopathic Arthritis and Growing Countries

Health Professionals in Rheumatology Practice and Clinical Care

1Shereen Abdalfattah Algergawy 1Faculty of Medicine Benha University Background: The purpose of this review study  is to evaluate the creation and switch from biological to biosimilar in juvenile idiopathic arthritis, mainly in low financial countries. Biosimilar versions of original biologic agents used in a wide range of chronic inflammatory diseases including  juvenile idiopathic arthritis, the…

Hospitalizations Outcomes in Patients with Systemic Lupus Erythematosus in a Large Tertiary Center with Multinational Population

Clinical Research

1Miral Hamed Ahmed Gharib,1Karima Becetti, 1Fiaz Alam, 1Aishwariya Padmakumari, 1Mohamed AL Kahlout, 1Rawan Saleh, 1Amina Bougalia, 1Bilal Jamshaid, 1Samar AL-Emadi 1Hamad Medical Corporation Background: Systemic Lupus Erythematosus is characterized by diverse clinical presentations and a remarkably unpredictable course. Although survival rate has increased in recent decades, morbidity and mortality are still substantially high, resulting in…